Short-term and long-term asthma control in patients with mild persistent asthma receiving montelukast or fluticasone: A randomized controlled trial

American Journal of Medicine

Volumn 118, Issue 6, 2005, Pages 649-657

  Zeiger, Robert S ^a   Bird, Steven R ^b   Kaplan, Michael S ^c   Schatz, Michael ^a   Pearlman, David S ^d   Orav, E John ^e   Hustad, Carolyn M ^b   Edelman, Jonathan M ^b  

^a KAISER PERMANENTE MEDICAL CENTER   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c Southern California Center for Medical Education   (United States)

^d Respiratory Institute   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Fluticasone; inhaled corticosteroids; Leukotriene receptor antagonist; Mild persistent asthma; Montelukast; severity

Indexed keywords

FLUTICASONE; MONTELUKAST;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TREATMENT OUTCOME;

ACETATES; ADMINISTRATION, INHALATION; ADMINISTRATION, ORAL; ANDROSTADIENES; ANTI-ASTHMATIC AGENTS; ASTHMA; DOUBLE-BLIND METHOD; FORCED EXPIRATORY VOLUME; HUMANS; QUINOLINES; TREATMENT OUTCOME;

EID: 19544388923     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2005.03.003     Document Type: Article

References (32)

1. National Institutes of Health and National Heart Lung and Blood Institute Global Initiative for Asthma Pocket Guide for Asthma Management and Prevention 2002 Bethesda, MD
2. National Asthma Education and Prevention Program Expert Panel Report Guidelines for the Diagnosis and Management of Asthma Update on Selected Topics--2002 J Allergy Clin Immunol. 110 5 suppl 2002 S141 S219
3. D. Olivieri, A. Chetta, M. Del Donno Effect of short-term treatment with low-dose inhaled fluticasone propionate on airway inflammation and remodeling in mild asthma a placebo-controlled study Am J Respir Crit Care Med. 155 1997 1864 1871
4. S.L. Chisholm, F.W. Dekker, N.A. Knuistingh, H. Petri Once-daily budesonide in mild asthma Respir Med. 92 1998 421 425
5. G. Jonasson, K.H. Carlsen, P. Blomqvist Clinical efficacy of low-dose inhaled budesonide once or twice daily in children with mild asthma not previously treated with steroids Eur Respir J. 12 1998 1099 1104
6. J.A. Leff, W.W. Busse, D. Pearlman Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction N Engl J Med. 339 1998 147 152
7. I. Herjavecz, P. Blomqvist, A. Serrano Efficacy of once- and twice-daily administration of budesonide via Turbuhaler as initial therapy in patients with mild persistent asthma Respir Med. 93 1999 230 235
8. J.T. Li, L.B. Ford, P. Chervinsky Fluticasone propionate powder and lack of clinically significant effects on hypothalamic-pituitary-adrenal axis and bone mineral density over 2 years in adults with mild asthma J Allergy Clin Immunol. 103 1999 1062 1068
9. F.A. Vermetten, A.J. Boermans, W.D. Luiten Comparison of salmeterol with beclomethasone in adult patients with mild persistent asthma who are already on low-dose inhaled steroids J Asthma. 36 1999 97 106
10. G. Jonasson, K.H. Carlsen, P. Mowinckel Asthma drug adherence in a long-term clinical trial Arch Dis Child. 83 2000 330 333
11. P.M. O'Byrne, P.J. Barnes, R. Rodriguez-Roisin Low dose inhaled budesonide and formoterol in mild persistent asthma the OPTIMA randomized trial Am J Respir Crit Care Med. 164 2001 1392 1397
12. G. Riccioni, E. Ballone, N. D'Orazio Effectiveness of montelukast versus budesonide on quality of life and bronchial reactivity in subjects with mild-persistent asthma Int J Immunopathol Pharmacol. 15 2002 149 155
13. G. Riccioni, R.D. Vecchia, M. Castronuovo Mild persistent asthma therapy inhalatory steroids or antileukotrienes Chest. 120 2001 221S
14. O.J. Dempsey, G. Kennedy, B.J. Lipworth Comparative efficacy and anti-inflammatory profile of once-daily therapy with leukotriene antagonist or low-dose inhaled corticosteroid in patients with mild persistent asthma J Allergy Clin Immunol. 109 2002 68 74
15. R.A. Pauwels, S. Pedersen, W.W. Busse Early intervention with budesonide in mild persistent asthma a randomised, double-blind trial Lancet. 361 2003 1071 1076
16. American Thoracic Society Standardization of spirometry, 1994 Update Am J Respir Crit Care Med. 152 1995 1107 1136
17. R.O. Crapo, A.H. Morris, R.M. Gardner Reference spirometric values using techniques and equipment that meet ATS recommendations Am Rev Respir Dis. 123 1981 659 664
18. N. Steen, A. Hutchinson, E. McColl Development of a symptom based outcome measure for asthma BMJ. 309 1994 1065 1068
19. W.M. Vollmer, L.E. Markson, E. O'Connor Association of asthma control with health care utilization and quality of life Am J Respir Crit Care Med. 160 1999 1647 1652
20. E.F. Juniper, G.H. Guyatt, R.S. Epstein Evaluation of impairment of health related quality of life in asthma development of a questionnaire for use in clinical trials Thorax. 47 1992 76 83
21. C. Demuro-Mercon, J. Turpin, N. Santanello Montelukast improves asthma quality of life when added to fluticasone J Allergy Clin Immunol. 107 2001 S248 S249
22. G.L. Hughes, J.M. Edelman, J.A. Turpin Randomized, open-label pilot study comparing the effects of montelukast sodium tablets, fluticasone aerosol inhaler and budesonide dry powder inhaler on asthma control in mild asthmatics Am J Respir Crit Care Med. 159 1999 A641
23. R.G. Newcombe Interval estimation for the difference between independent proportions comparison of eleven methods Stat Med. 17 1998 873 890
24. R. Zeiger, J.W. Baker, M.S. Kaplan Variability of symptoms in mild persistent asthma baseline data from the MIAMI study Respir Med. 98 2004 898 905
25. Y.Y. Meng, K.M. Leung, D. Berkbigler Compliance with US asthma management guidelines and specialty care a regional variation or national concern? J Eval Clin Pract. 5 1999 213 221
26. G.L. Colice, J.V. Burgt, J. Song Categorizing asthma severity Am J Respir Crit Care Med. 160 1999 1962 1967
27. D.M. Mannino, D.M. Homa, C.A. Pertowski Surveillance for asthma--United States, 1960-1995 MMWR CDC Surveill Summ. 47 1998 1 27
28. D.M. Mannino, D.M. Homa, L.J. Akinbami Surveillance for asthma--United States, 1980-1999 MMWR Surveill Summ. 51 2002 1 13
29. A.L. Fuhlbrigge, R.J. Adams, T.W. Guilbert The burden of asthma in the United States level and distribution are dependent on interpretation of the national asthma education and prevention program guidelines Am J Respir Crit Care Med. 166 2002 1044 1049
30. J. Zhang, C. Yu, S.T. Holgate, T.F. Reiss Variability and lack of predictive ability of asthma end-points in clinical trials Eur Respir J. 20 2002 1102 1109
31. W.J. Calhoun, L.B. Sutton, A. Emmett, P.M. Dorinsky Asthma variability in patients previously treated with beta2-agonists alone J Allergy Clin Immunol. 112 2003 1088 1094
32. F.M. Ducharme Inhaled glucocorticoids versus leukotriene receptor antagonists as single agent asthma treatment systematic review of current evidence BMJ. 326 2003 621 623